LCMV gp33-41-5 mg

Description

LCMV gp33-41, the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-anti-virus–C48H73N11O13S—-[1]Gairin JE, et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol. 1995 Apr;69(4):2297-305.–151705-84-9–1044.22–99.08–[K][*][V]/[Y]([*]([M])[3H])=N/F–Inflammation/Immunology–H2O : 12.5 mg/mL (ultrasonic)–Arenavirus—-Anti-infection–Peptides